​

FibroGen (FGEN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FGEN Stock Forecast

FibroGen (FGEN) stock forecast, based on 2 Wall Street analysts, predicts a 12-month average price target of $28.00, with a high of $28.00 and a low of $28.00. This represents a 5733.33% increase from the last price of $0.48.

- $6 $12 $18 $24 $30 High: $28 Avg: $28 Low: $28 Last Closed Price: $0.48

FGEN Stock Rating

FibroGen stock's rating consensus is Buy, based on 2 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (50.00%), 1 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 2 0 1 1 Strong Sell Sell Hold Buy Strong Buy

FGEN Forecast vs Benchmarks

TypeNameUpside
StockFibroGen5733.33%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.48$0.48$0.48
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25--1--1
Dec, 24--1-12
Nov, 245-2-18
Oct, 245-2119
Sep, 245-21-8
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 02, 2023Annabel SamimyStifel Nicolaus$28.00$17.3261.66%5733.33%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jul 31, 2024William BlairMarket PerformMarket Performhold
Jan 30, 2023William BlairOutperformupgrade
Jan 05, 2023Bank of America SecuritiesBuyupgrade

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.11$-3.15$-3.15$-2.92-----
Avg Forecast$-1.70$-2.50$-3.37$-2.63$-0.80$-0.46$-0.38$0.25$-0.44
High Forecast$-1.72$-2.54$-3.75$-2.69$-0.86$-0.52$-0.44$0.21$-0.51
Low Forecast$-1.67$-2.46$-3.00$-2.56$-0.74$-0.38$-0.32$0.30$-0.37
Surprise %24.12%26.00%-6.53%11.03%-----

Revenue Forecast

$100M $150M $200M $250M $300M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$176.32M$235.31M$140.73M$147.75M-----
Avg Forecast$212.12M$267.58M$130.85M$164.01M$177.84M$166.17M$178.16M$224.84M$270.40M
High Forecast$209.58M$264.39M$119.78M$143.13M$176.99M$145.02M$178.08M$218.91M$235.98M
Low Forecast$214.65M$270.78M$141.92M$184.89M$178.69M$187.32M$178.24M$230.77M$304.82M
Surprise %-16.88%-12.06%7.55%-9.91%-----

Net Income Forecast

$-550M $-430M $-310M $-190M $-70M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-189.29M$-291.03M$-295.23M$-284.23M-----
Avg Forecast$-164.94M$-121.49M$-71.28M$-284.23M$-77.84M$-43.81M$-36.93M$24.64M$-42.81M
High Forecast$-167.51M$-217.49M$-152.59M$-529.25M$-83.68M$-51.03M$-43.04M$20.56M$-49.90M
Low Forecast$-162.39M$-25.48M$10.02M$-39.22M$-72.00M$-36.58M$-30.82M$28.71M$-35.73M
Surprise %14.76%139.56%314.16%------

FGEN Forecast FAQ

Is FibroGen stock a buy?

FibroGen stock has a consensus rating of Buy, based on 2 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that FibroGen is a favorable investment for most analysts.

What is FibroGen's price target?

FibroGen's price target, set by 2 Wall Street analysts, averages $28 over the next 12 months. The price target range spans from $28 at the low end to $28 at the high end, suggesting a potential 5733.33% change from the previous close price of $0.48.

How does FibroGen stock forecast compare to the average forecast of its sector, industry, and investment themes?

FibroGen stock forecast shows a 5733.33% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for FibroGen over the past three months?

  • January 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 50.00% Strong Sell.
  • November 2024: 62.50% Strong Buy, 0% Buy, 25.00% Hold, 0% Sell, 12.50% Strong Sell.

What is FibroGen’s EPS forecast?

FibroGen's average annual EPS forecast for its fiscal year ending in December is -0.8 for 2024, a -72.60% decrease from the reported $-2.92 in 2023. The prediction for 2025 is $-0.46, $-0.38 for 2026, $0.25 for 2027, and $-0.44 for 2028.

What is FibroGen’s revenue forecast?

FibroGen's average annual revenue forecast for its fiscal year ending in December is $177.84M for 2024, a 20.37% increase from the reported $147.75M in 2023. The forecast for 2025 is $166.17M, $178.16M for 2026, $224.84M for 2027, and $270.4M for 2028.

What is FibroGen’s net income forecast?

For its fiscal year ending in December, FibroGen's average annual net income forecast is $-77.838M for 2024, reflecting a -72.61% decrease from the reported $-284M in 2023. The projection for 2025 is $-43.806M, $-36.931M for 2026, $24.64M for 2027, and $-42.813M for 2028.